Cargando…

CDK12 and PAK2 as novel therapeutic targets for human gastric cancer

Background: Gastric cancer remains the second leading cause of cancer-related death, and the third in mortality due to lack of effective therapeutic targets for late stage cancer patients. This study aims to identify potential druggable target biomarkers as potential therapeutic options for patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hui, Shin, Seung Ho, Chen, Hanyong, Liu, Tingting, Li, Zhi, Hu, Yamei, Liu, Fangfang, Zhang, Chengjuan, Kim, Dong Joon, Liu, Kangdong, Dong, Zigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255043/ https://www.ncbi.nlm.nih.gov/pubmed/32483448 http://dx.doi.org/10.7150/thno.46137

Ejemplares similares

Targeting integrin αvβ3 with indomethacin inhibits patient‐derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma
por: Liu, Fangfang, et al.
Publicado: (2021)

Cirsiliol targets tyrosine kinase 2 to inhibit esophageal squamous cell carcinoma growth in vitro and in vivo
por: Jia, Xuechao, et al.
Publicado: (2021)

Honokiol Inhibits Melanoma Growth by Targeting Keratin 18 in vitro and in vivo
por: Liu, Tingting, et al.
Publicado: (2020)

Carnosol suppresses patient-derived gastric tumor growth by targeting RSK2
por: Wang, Li, et al.
Publicado: (2018)

The Role of p21-Activated Kinases in Cancer and Beyond: Where Are We Heading?
por: Liu, Hui, et al.
Publicado: (2021)

Nuplazid suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting PAK4
por: Wei, Yaxing, et al.
Publicado: (2021)

244-MPT overcomes gefitinib resistance in non-small cell lung cancer cells
por: Zhang, Yi, et al.
Publicado: (2015)

APIO-EE-9 is a novel Aurora A and B antagonist that suppresses esophageal cancer growth in a PDX mouse model
por: Jin, Guoguo, et al.
Publicado: (2017)

A Small Molecule Inhibitor of the β-Catenin-TCF4 Interaction Suppresses Colorectal Cancer Growth In Vitro and In Vivo
por: Shin, Seung Ho, et al.
Publicado: (2017)

2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo
por: Zu, Xueyin, et al.
Publicado: (2020)

Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo
por: Liu, Xuejiao, et al.
Publicado: (2019)

PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential
por: Huang, Hai, et al.
Publicado: (2021)

Inhibition of LTA4H by bestatin in human and mouse colorectal cancer
por: Zhao, Simin, et al.
Publicado: (2019)

Heterogeneity Analysis of Esophageal Squamous Cell Carcinoma in Cell Lines, Tumor Tissues and Patient-Derived Xenografts
por: Ma, Fayang, et al.
Publicado: (2021)

Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing Tetraploidization
por: Yeung, Yiu To, et al.
Publicado: (2018)

3,3'-Diindolylmethane plus Eflornithine suppress DNA Replication and Cell Cycle in Esophageal Squamous Cell Carcinoma in vivo
por: Ma, Fayang, et al.
Publicado: (2022)

Knockdown of Pyruvate Kinase M Inhibits Cell Growth and Migration by Reducing NF-κB Activity in Triple-Negative Breast Cancer Cells
por: Ma, Chaobing, et al.
Publicado: (2019)

Dasatinib Inhibits Lung Cancer Cell Growth and Patient Derived Tumor Growth in Mice by Targeting LIMK1
por: Zhang, Man, et al.
Publicado: (2020)

Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy
por: Du, Ruijuan, et al.
Publicado: (2021)

PAK1-mediated MORC2 phosphorylation promotes gastric tumorigenesis
por: Wang, Guiling, et al.
Publicado: (2015)

GL-1196 Suppresses the Proliferation and Invasion of Gastric Cancer Cells via Targeting PAK4 and Inhibiting PAK4-Mediated Signaling Pathways
por: Zhang, Jian, et al.
Publicado: (2016)

Targeting ornithine decarboxylase (ODC) inhibits esophageal squamous cell carcinoma progression
por: He, Wei, et al.
Publicado: (2017)

Mitochondrial PAK6 inhibits prostate cancer cell apoptosis via the PAK6-SIRT4-ANT2 complex
por: Li, Tingting, et al.
Publicado: (2020)

Precision medicine: the foundation of future cancer therapeutics
por: Shin, Seung Ho, et al.
Publicado: (2017)

Acetylshikonin suppressed growth of colorectal tumour tissue and cells by inhibiting the intracellular kinase, T‐lymphokine‐activated killer cell‐originated protein kinase.
por: Zhao, Ran, et al.
Publicado: (2020)

PAK1 and PAK4 as therapeutic targets for Ewing sarcoma: a commentary
por: Parks, Sydney E., et al.
Publicado: (2021)

Anwulignan is a novel JAK1 inhibitor that suppresses non‐small cell lung cancer growth
por: Xie, Xiaomeng, et al.
Publicado: (2021)

Xanthohumol Inhibits the Growth of Keratin 18-Overexpressed Esophageal Squamous Cell Carcinoma in vitro and in vivo
por: Yin, Shuying, et al.
Publicado: (2020)

Functional Deficits in Pak5, Pak6 and Pak5/Pak6 Knockout Mice
por: Furnari, Melody A., et al.
Publicado: (2013)

Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRC
por: Li, Mingzhu, et al.
Publicado: (2023)

Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
por: Yin, Fanxiang, et al.
Publicado: (2022)

Direct Interaction between AR and PAK6 in Androgen-Stimulated PAK6 Activation
por: Liu, Xia, et al.
Publicado: (2013)

Oxethazaine inhibits esophageal squamous cell carcinoma proliferation and metastasis by targeting aurora kinase A
por: Bao, Zhuo, et al.
Publicado: (2022)

Ipriflavone Suppresses Growth of Esophageal Squamous Cell Carcinoma Through Inhibiting mTOR In Vitro and In Vivo
por: Shi, Xiaodan, et al.
Publicado: (2021)

Prognostic Importance and Therapeutic Implications of PAK1, a Drugable Protein Kinase, in Gastroesophageal Junction Adenocarcinoma
por: Li, Zongtai, et al.
Publicado: (2013)

PAK4 signaling in health and disease: defining the PAK4–CREB axis
por: Won, So-Yoon, et al.
Publicado: (2019)

Group I Paks as therapeutic targets in NF2-deficient meningioma
por: Chow, Hoi-Yee, et al.
Publicado: (2015)

Discovery of a molecular glue promoting CDK12-DDB1 interaction to trigger cyclin K degradation
por: Lv, Lu, et al.
Publicado: (2020)

PPMP, a novel tubulin-depolymerizing agent against esophageal cancer in patient-derived tumor xenografts
por: Sheng, Yuqiao, et al.
Publicado: (2016)

PAK1, PAK1Δ15, and PAK2: similarities, differences and mutual interactions
por: Grebeňová, Dana, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pi9l6fhs0kt07ill2l5q5q3tm9